| Name | Title | Contact Details |
|---|
The Volkswagen Group with its headquarters in Wolfsburg is one of the worlds leading automobile manufacturers and the largest carmaker in Europe. The Group is made up of ten brands from seven European countries: Volkswagen, Volkswagen Nutzfahrzeuge, ŠKODA, SEAT, CUPRA, Audi, Lamborghini, Bentley, Porsche and Ducati. Our group sells vehicles in 153 countries and operates 114 production plants worldwide. Each working day, around 675,000 employees worldwide produce cars, are involved in vehicle-related services or work in the other fields of business. Our goal is to make mobility sustainable for us and for future generations. Our promise: With electric drive, digital networking and autonomous driving, we make the automobile clean, quiet, intelligent and safe. At the same time, our core product becomes even more emotional and offers a completely new driving experience. It is also becoming part of the solution when it comes to climate and environmental protection. In this way, the car can continue to be a cornerstone of contemporary, individual and affordable mobility in the future. #Shapingmobility Imprint & Legal: http://vw.de/legal-notice DAT: http://vw.de/dat
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Northeast Precast is a state-of-the-art facility located in Vineland, NJ. It is our mission to become the preferred supplier in the Mid-Atlantic precast concrete market by providing operational excellence and superior customer service. Northeast Precast Advantage •(2) 50,000 sq ft Heated Indoor Casting Facilities •(16) Overhead Cranes (Up to 40 Ton Capacity) •(3) Gantry cranes (Up to 70 Ton Capacity) •30,000 sq ft Indoor Fabrication Shop •High Definition Plasma Cutter •Forms & Custom Trailers are Made In-house •(2) Concrete Batch Plants •Designated In-house Fleet of Tractors & Trailers